Meta Loses EU Court Fight Over Antitrust Crackdown on Data
Meta Platforms Inc.’s Facebook lost its European Union court fight over a German antitrust order that homed in
2023-07-04 19:21
Signa Files for Insolvency as Cash Crunch Fells Luxury Empire
Tycoon Rene Benko’s Signa filed for insolvency after a last-ditch attempt to raise emergency funding failed, making the
2023-11-29 18:56
Texas battery rush: Oil state's power woes fuel energy storage boom
By Nichola Groom and Laila Kearney BlackRock, Korea's SK, Switzerland's UBS and other companies are chasing an investment
2023-05-31 18:28
IOC to explore Olympic eSports Games
The International Olympic Committee is looking at creating an Olympic eSports Games, IOC president Thomas Bach...
2023-10-15 00:48
PPG opens customer and employee experience center at global headquarters, marks 140th anniversary
PITTSBURGH--(BUSINESS WIRE)--Aug 23, 2023--
2023-08-23 20:50
Yellen says US economy does not need drastic tightening, 'soft landing' on track
By Howard Schneider BESSEMER CITY, North Carolina U.S. Treasury Secretary Janet Yellen said on Thursday she believes the
2023-12-01 03:22
Aviva Trims Portfolio With SingLife Exit: The London Rush
Aviva is selling its stake in Singapore Life Holdings as the insurer continues to trim its portfolio around
2023-09-13 15:45
Argentina’s Milei Keeps Edge Over Massa With One Week to Go Before Presidential Runoff
Javier Milei, the libertarian outsider promising to scrap Argentina’s currency and central bank, continues to hold a slight
2023-11-11 03:54
Bee Rx™ Natural Skincare Launches in Canada
TORONTO--(BUSINESS WIRE)--Jun 27, 2023--
2023-06-27 19:24
Humana Rises as Insurer Sees Medical Costs Stabilizing
Humana Inc. shares jumped in trading before US markets opened after the insurer said an uptick in medical
2023-08-02 20:58
Lucid cuts full-year production forecast
(Reuters) -Lucid Group said on Tuesday it now expects to produce 8,000–8,500 vehicles this year from its earlier projection of
2023-11-08 05:27
Novo Nordisk in $1.3 billion deal to buy hypertension drug
COPENHAGEN Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular
2023-10-16 19:20
You Might Like...
Muddy Waters’s Latest Target Follows String of Notable Wins
G-20 Latest: World Bank Chief Aims to Boost Lending Ability
Work resumes on $10B renewable energy transmission project despite tribal objections
Lucid shares drop as deliveries take hit from Tesla's price war
Don't expect markets to rejoice if a deal is reached on the debt ceiling
2023 Blue Planet Prize: Announcement of Prize Winners
Hawaiian Electric stock plunges 40% after lawsuit alleges it failed to shut power off ahead of the Maui wildfires
US DOJ brings meat industry antitrust case against data company Agri Stats